**Executive Summary**
This report details the status and performance of Jan Aushadhi Kendras (JAKs) in the Tonk and Sawai Madhopur districts of Rajasthan as of March 2026. It highlights sales growth, supply chain improvements, and the government's strategic measures to ensure medicine availability. A key national target is set to increase the total number of JAKs to 25,000 by the end of March 2027.
**Key Points / Main Content**
**Regional Operations and Sales**
* There are currently 11 functional JAKs in Tonk and 13 in Sawai Madhopur.
* Sales at MRP in Sawai Madhopur rose from ₹0.47 Crore in FY 2023-24 to ₹0.62 Crore by February 2026.
* Sales in Tonk rose from ₹0.07 Crore in FY 2023-24 to ₹0.18 Crore by February 2026.
* All Kendras must obtain approval from the Pharmaceuticals and Medical Devices Bureau of India (PMBI) and licenses from State Drug Licensing Authorities.
**Supply Chain Management**
* An IT-enabled supply chain connects one central warehouse, four regional warehouses, and 41 distributors.
* The PMBI regularly monitors 400 fast-moving products and conducts ongoing demand forecasting.
* Procurement processes are being augmented through digitized and automated forecasting methods.
**Inventory Incentives**
* Since September 2024, JAK owners are eligible for monthly incentives for stocking 200 commonly used medicines.
* This stock includes the top 100 selling medicines in the scheme and the top 100 fast-selling medicines in the general market.
**Impact Analysis**
**Jan Aushadhi Kendra (JAK) Owners**
**Impact**
Owners are now eligible for monthly financial incentives tied to maintaining specific inventory levels of high-demand medicines.
**Action Required**
Maintain consistent stocks of the 200 identified commonly used medicines to qualify for incentives and address supply gaps.
**Pharmaceuticals and Medical Devices Bureau of India (PMBI)**
**Impact**
As the implementing agency, the PMBI is responsible for overseeing the expansion of the network and monitoring product demand.
**Action Required**
Continue regular monitoring of 400 fast-moving products and implement digitized forecasting to automate procurement.
**General Public (Patients)**
**Impact**
The expansion of the JAK network, particularly in backward and remote areas, increases the accessibility of affordable medicines.
**Action Required**
No specific action required; patients benefit from improved product availability and the establishment of new centers.
**Government of India / Department of Pharmaceuticals**
**Impact**
The government is committed to a significant national expansion of the program to improve healthcare affordability.
**Action Required**
Work toward the target of establishing 25,000 JAKs across the country by the deadline of March 2027.
Key Entities Referenced
Jan Aushadhi Kendras (JAKs): Outlets established to provide affordable medicines and health products to the public under a government initiative.
Pharmaceuticals and Medical Devices Bureau of India (PMBI): The primary implementing agency responsible for approving, monitoring, and managing the automated supply chain for the kendras.
Department of Pharmaceuticals: The government department under the Ministry of Chemicals and Fertilizers overseeing the Jan Aushadhi Kendra initiative.
Tonk and Sawai Madhopur, Rajasthan: The specific geographic focus areas where the functional status and sales performance of Jan Aushadhi Kendras are reported.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Jan Aushadi Kendras in Sawai Madhopur
Posted On: 20 MAR 2026 2:59PM by PIB Delhi
A total of 11 Jan Aushadhi Kendras (JAKs) are functional in the Tonk district and 13 JAKs are functional
in the Sawai Madhopur district of Sawai Modhopur Lok Sabha Constituency of Rajasthan. These Kendras
are established and made functional after obtaining initial approval from Pharmaceuticals and Medical
Devices Bureau of India (PMBI) and obtaining of requisite license from State Drug Licensing
Authorities.
Year-wise sale at MRP (in ₹ Crore) of Jan Aushadhi Kendras functional in the Tonk and Sawai Madhopur
districts during last three financial year are as under: -
(In ₹ Crore)
Sl. No. Financial Year Tonk Sawai Madhopur
1. 2023-24 0.07 0.47
2. 2024-25 0.20 0.66
3. 2025-26 0.18 0.62
(Till 28.02.2026)
With a view to address any supply gaps and ensure smooth supply and product availability at JAKs, the
following measures are in place:
i. Since September 2024, stocking by JAKs of 200 commonly used medicines, consisting of the
100 top-selling medicines in the scheme product basket and 100 fast-selling medicines in the
market, has been incentivised, under which JAK owners are eligible for monthly incentive
based on the stocks that they maintain of these medicines.
ii. An end-to-end information-technology-enabled supply chain system is in place to connect a
robust supply chain system consisting of one central warehouse, four regional warehouses and
a growing network of distributors across the country, currently numbering 41.
iii. In addition, with a view to ensure availability of commonly used products, 400 fast-moving
products are monitored regularly by the scheme implementing agency {Pharmaceuticals and
Medical Devices Bureau of India (PMBI)} and demand for the same is forecasted on an
ongoing basis. Further, steps have been taken to digitise the forecasting method to augment
the procurement process through automation.
Further, to ensure wider availability of affordable medicines across the country, including backward and
remote areas, the Government has set a target to increase in the total number of JAKs opened across the
country to 25,000 by end of March 2027.This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a
written reply in the Lok Sabha today.
*****
PC/PM
(Release ID: 2242924) Visitor Counter : 79
Read this release in: Urdu , ही